TTK Healthcare
NSE: TTKHLTCARE · Diversified
Snapshot
Unlock TTK Healthcare's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
TTK Healthcare is a diversified Indian company operating across animal welfare, human pharmaceuticals, consumer products, medical devices, protective devices, and food manufacturing. The company maintains a broad portfolio ranging from healthcare solutions and contraceptives to household consumer goods and publishing.
Business Model
The company generates revenue through the manufacturing, marketing, and distribution of a wide array of products across its six business segments. It leverages established brands like Woodward's and EVA to maintain market presence in both domestic and international markets.
- Incorporation Year:1958
- Headquarters:Chennai, India
Growth Outlook
Growth is driven by the expansion of its diverse product portfolio, including therapeutic veterinary formulations, orthopedic medical devices, and consumer-facing goods. The company continues to focus on its established distribution networks to penetrate deeper into its various market segments.
Key Risks
- Regulatory Risk. The company's pharmaceutical and medical device segments are subject to stringent government regulations and quality standards that may impact operational costs.
- Competitive Pressure. The consumer products and food segments face intense competition from both domestic and multinational players, potentially impacting profit margins.
- Supply Chain Volatility. Fluctuations in raw material costs for food products and pharmaceutical ingredients could adversely affect the company's financial performance.
- Market Concentration. As a diversified entity, the company faces the challenge of managing disparate business cycles across its various segments simultaneously.
Start your research today
Unlock AI insights, financials, peers and live data on TTK Healthcare and 5,000+ companies — free.
Key Metrics
REVENUE
₹888 Cr
TTM · standalone
NET PROFIT
₹74 Cr
TTM · standalone
EPS
₹52.34
TTM · standalone
RETURN ON EQUITY
6.8%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
8.8%
TTM · standalone
P/E
21.0x
Q1 FY27 · standalone
EV/EBITDA
14.2x
Q1 FY27 · standalone
EBITDA MARGIN
12.3%
TTM · standalone
NET PROFIT MARGIN
8.3%
Q1 FY27 · standalone
DEBT TO EQUITY
0.0x
Q1 FY27 · standalone
Peers · Diversified
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
TTK HealthcareTTKHLTCARE | ₹1,555 Cr | 21.02 | 14.25 | 8.3% | 12.3% | 6.8% | 8.8% | -3.2% |
3M India Ltd.3MINDIA | ₹37,000 Cr | 64.05 | 35.39 | 15.7% | 19.3% | 32.0% | 50.8% | +7.8% |
DCM Shriram Ltd.DCMSHRIRAM | ₹15,920 Cr | 11.08 | 10.64 | 11.2% | 11.9% | 19.5% | 12.7% | -18.3% |
Balmer Lawrie & Co. Ltd.BALMLAWRIE | ₹3,044 Cr | 10.90 | 7.43 | 8.9% | 14.9% | 12.7% | 13.6% | -22.3% |
Dhunseri Ventures LimitedDVL | ₹1,016 Cr | 5.24 | 60.63 | -22.9% | 6.8% | 5.9% | 0.1% | -15.0% |
Empire Industries LimitedEMPIND | ₹717 Cr | 13.92 | 7.32 | 8.0% | 14.4% | 15.5% | 16.1% | +2.6% |
As of Q1 FY27
Financials
TTK Healthcare
NSE: TTKHLTCARE · Diversified
Snapshot
Unlock TTK Healthcare's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
TTK Healthcare is a diversified Indian company operating across animal welfare, human pharmaceuticals, consumer products, medical devices, protective devices, and food manufacturing. The company maintains a broad portfolio ranging from healthcare solutions and contraceptives to household consumer goods and publishing.
Business Model
The company generates revenue through the manufacturing, marketing, and distribution of a wide array of products across its six business segments. It leverages established brands like Woodward's and EVA to maintain market presence in both domestic and international markets.
- Incorporation Year:1958
- Headquarters:Chennai, India
Growth Outlook
Growth is driven by the expansion of its diverse product portfolio, including therapeutic veterinary formulations, orthopedic medical devices, and consumer-facing goods. The company continues to focus on its established distribution networks to penetrate deeper into its various market segments.
Key Risks
- Regulatory Risk. The company's pharmaceutical and medical device segments are subject to stringent government regulations and quality standards that may impact operational costs.
- Competitive Pressure. The consumer products and food segments face intense competition from both domestic and multinational players, potentially impacting profit margins.
- Supply Chain Volatility. Fluctuations in raw material costs for food products and pharmaceutical ingredients could adversely affect the company's financial performance.
- Market Concentration. As a diversified entity, the company faces the challenge of managing disparate business cycles across its various segments simultaneously.
Start your research today
Unlock AI insights, financials, peers and live data on TTK Healthcare and 5,000+ companies — free.
Key Metrics
REVENUE
₹888 Cr
TTM · standalone
NET PROFIT
₹74 Cr
TTM · standalone
EPS
₹52.34
TTM · standalone
RETURN ON EQUITY
6.8%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
8.8%
TTM · standalone
P/E
21.0x
Q1 FY27 · standalone
EV/EBITDA
14.2x
Q1 FY27 · standalone
EBITDA MARGIN
12.3%
TTM · standalone
NET PROFIT MARGIN
8.3%
Q1 FY27 · standalone
DEBT TO EQUITY
0.0x
Q1 FY27 · standalone
Peers · Diversified
As of Q1 FY27